Biotechnology Regs Raise Ruckus

A new set of biotechnology regulations for the state of Minnesota, approved by an administrative law judge in mid-March, have many researchers in the state alarmed. The scientists are disturbed not so much by the rules themselves--which require the obtaining of state permits for field tests of transgenic plants and microbes and the registration of labs working with recombinant organisms--as by the atmosphere surrounding their drafting. According to Jeff Tate, a plant physiologist at the Univer

Written byScott Veggeberg
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

According to Jeff Tate, a plant physiologist at the University of Minnesota and a spokesman for the Minnesota Biotechnology Association, activists opposed to biotechnology were heavily involved in the development of the Minnesota rules, written to codify biotech legislation passed over the past two years. Tate says these activists could erect barriers to field testing of transgenic plants by petitioning for public hearings on each permit application and by instituting negative publicity campaigns.

By contrast, in North Carolina--the only other state with such sweeping regulations--the state biotech- nology council claims that researchers have fared well under North Carolina's two-year- old permit process, which was developed in a probiotechnology environment.

Richard Zink, who as assistant director of the plant industry division at the Minnesota Department of Agriculture will administer the permit process, says, "There's no doubt that environmental groups have targeted Minnesota with this issue." Tate says the targeting includes outbursts ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies